Head And Neck Cancer Diagnostics Market size to grow by USD 4.93 billion from 2022-2027 | AbbVie Inc., Accuray Inc., AdDent Inc. and more among the key companies in the market - Technavio

NEW YORK, Dec. 12, 2023 /PRNewswire/ -- The Head and Neck Cancer Diagnostic Methods Market size is expected to grow by USD 4.93 billion, accelerating at a CAGR of 12.2% during the forecast period, according to Technavio Research. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including: AbbVie Inc., Accuray Inc., AdDent Inc., Bristol Myers Squibb Co., Canon Inc., Carestream Health Inc., Eli Lilly and Co., Esaote Spa, Flexicare Group Ltd., General Electric Co., Hitachi Ltd., KARL STORZ SE and Co. KG, Koninklijke Philips N.V., Olympus Corp., Optim LLC, Shimadzu Corp., Siemens AG, Sumitomo Mitsui Financial Group, Xoran Technologies LLC and Merck KGaA. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read PDF Sample Report

Head And Neck Cancer Diagnostics Market: Company Offerings

AbbVie Inc: The company offers head and neck cancer diagnostics such as ABBV 368 for the treatment of solid tumors such as triple negative breast cancer, non-small cell lung cancer, ecurrent and metastatic, head and neck squamous cell carcinoma, and many more.

To gain access to more company profiles available with Technavio, buy the report

Head And Neck Cancer Diagnostics Market: Segmentation Analysis

The market is segmented by Diagnostic Methods (Biopsy and blood tests, Imaging, Endoscopy, and Dental diagnostics), End-user (Hospitals, Specialty clinics, Ambulatory surgical centers, and Others), and Geography (North America, Europe, Asia, and Rest of World (ROW)).

The biopsy and blood tests segment is expected to experience substantial market share growth during the forecast period. A biopsy is a laboratory procedure involving in the removal of a tissue or cell sample for analysis. Its primary purpose is diagnosing cancer. Various types of biopsies used in diagnosing head and neck cancer include incisional biopsy, fine needle aspiration (FNA) biopsy, and human papillomavirus (HPV) testing.

Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report

Head And Neck Cancer Diagnostics Market: Driver & Trend:

Driver

• Increasing incidences of head and neck cancers, constituting about 4% of US cancer cases, with approximately 562,328 global diagnoses in 2020.
• In the UK, there are around 12,000 yearly diagnoses of head and neck cancer, alongside 8,300 oral cancer cases (1 in 50 cancers diagnosed).
• This increasing prevalence drives an anticipated rise in demand for head and neck cancer diagnosis during the forecast period.

Trend - The growing trend of oncology tourism is the primary trend shaping the market growth.

Identify key trends, drivers, and challenges in the market. Download the sample report to gain access to this information

Related Reports:

Head and Neck Cancer Treatment Market: The head and neck cancer treatment market size is estimated to grow by USD 5,077.38 million at a CAGR of 11.27% between 2022 and 2027.

Cancer Diagnostics Market: The Global Cancer Diagnostics Market size is estimated to grow at a CAGR of 11.3% between 2022 and 2027. The market size is forecast to increase by USD 12,626.21 million.

What are the key data covered in this head and neck cancer diagnostics market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the head and neck cancer diagnostics market between 2022 and 2027.
• Precise estimation of the head and neck cancer diagnostics market size and its contribution to the market in focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of head and neck cancer diagnostics market vendors.

ToC:

1. Executive Summary
2. Market Landscape
3. Market Sizing
4. Historic Market Sizes
5. Five Forces Analysis
6. Market Segmentation by Disgnostic Methods
7. Market Segmentation by End-User
8. Market Segmentation by Geography
9. Customer Landscape
10. Geographic Landscape
11. Drivers, Challenges, & Trends
12. Company Landscape
13. Company Analysis
14. Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio